{"denoms":[{"counts":[{"groupId":"BG000","value":"331"},{"groupId":"BG001","value":"330"},{"groupId":"BG002","value":"213"},{"groupId":"BG003","value":"874"}],"units":"Participants"}],"groups":[{"description":"Participants received Imlunestrant 400 milligrams (mg) orally once daily on days 1 to 28 of a 28-day cycle, until disease progression or a criterion for discontinuation were met.","id":"BG000","title":"Imlunestrant"},{"description":"Participants received the investigator's choice of endocrine therapy, either exemestane 25 mg administered orally once daily on days 1 to 28 of a 28-day cycle, or Fulvestrant 500 mg intramuscularly on days 1 and 15 of Cycle 1, then on Day 1 of Cycle 2 and beyond, until disease progression or a criterion for discontinuation was met.","id":"BG001","title":"Investigator's Choice of Endocrine Therapy"},{"description":"Participants received Imlunestrant 400 mg orally once daily on Days 1 to 28 of a 28-day cycle, plus Abemaciclib 150 mg orally twice daily on Days 1 to 28 of a 28-day cycle, until disease progression or a criterion for discontinuation was met.","id":"BG002","title":"Imlunestrant + Abemaciclib"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.6","value":"60.4"},{"groupId":"BG001","spread":"12.0","value":"60.8"},{"groupId":"BG002","spread":"11.1","value":"61.9"},{"groupId":"BG003","spread":"11.6","value":"60.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"327"},{"groupId":"BG001","value":"329"},{"groupId":"BG002","value":"211"},{"groupId":"BG003","value":"867"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"7"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"79"},{"groupId":"BG001","value":"80"},{"groupId":"BG002","value":"37"},{"groupId":"BG003","value":"196"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"218"},{"groupId":"BG001","value":"216"},{"groupId":"BG002","value":"148"},{"groupId":"BG003","value":"582"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"28"},{"groupId":"BG003","value":"96"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"42"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"92"},{"groupId":"BG001","value":"96"},{"groupId":"BG002","value":"72"},{"groupId":"BG003","value":"260"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"8"},{"groupId":"BG003","value":"26"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"186"},{"groupId":"BG001","value":"191"},{"groupId":"BG002","value":"111"},{"groupId":"BG003","value":"488"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"12"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"46"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"138"},{"groupId":"BG001","value":"118"},{"groupId":"BG002","value":"67"},{"groupId":"BG003","value":"323"}],"title":"Detected"},{"measurements":[{"groupId":"BG000","value":"193"},{"groupId":"BG001","value":"212"},{"groupId":"BG002","value":"146"},{"groupId":"BG003","value":"551"}],"title":"Not detected"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Estrogen Receptor 1 (ESR1)-Mutation","unitOfMeasure":"Participants"}],"populationDescription":"All randomized participants."}